UPDATE: Deutsche Bank Downgrades ResMed Following CMS Release
July 03, 2014 at 10:19 AM EDT
In a report published Thursday, Deutsche Bank analyst David Low downgraded the rating on ResMed (NYSE: RMD) from Buy to Hold, but ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.